SunBio,Inc. (KOSDAQ:067370)

South Korea · Delayed Price · Currency is KRW

6,060.00

-110.00 (-1.78%)

At close: Jun 26, 2026

-12.93% (1Y)

Market Cap	76.33B -17.9%
Revenue (ttm)	2.17B +2.3%
Net Income	1.39B
EPS	249.33
Shares Out	12.19M
PE Ratio	25.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,600
Open	6,170.00
Previous Close	6,170.00
Day's Range	5,930.00 - 6,290.00
52-Week Range	4,840.00 - 8,500.00
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1997

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 067370

Full Company Profile